How Precision Cancer Care Saved a Life

Ronaldo de Oliveira was close to death. The 33-year-old father of two young children had been diagnosed with myeloid sarcoma, a rare form of leukemia that worsened despite treatment with six different chemotherapy regimens. His wife pleaded with his oncologist, Richard Stone, MD, director of the Adult Leukemia Program at Dana-Farber, to find something else … Read more

How Genetics Can Help Predict — and Sometimes Stop — Childhood Cancers

Amy Kindstedt hates cancer, but the 9-year-old is very thankful for one thing: Because genetic testing on her baby brother Hunter revealed he had the same genetic mutation she did, his cancer was caught much earlier –  possibly sparing him the same level of intense treatment she endured. The mapping of the human genome has … Read more

Nine-Year-Old Honors Dad’s Cancer Journey by Supporting Other Patients

Peter Silveira took to calling his daughter, Hannah, a good luck charm during his treatment for gray-zone lymphoma in 2014-15. Now, with her dad’s cancer in remission, the grade-schooler – who accompanied him to several of his treatments at Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC) – has taken it upon herself to pass some of … Read more

Five Things Female Childhood Cancer Survivors Should Know

By Lisa Diller, MD While recent research shows improvement in long-term survival rates for childhood cancer patients, challenges remain for many of the almost 400,000 survivors in the United States. Among the long-term survivors are women facing gynecological health issues from the late effects of their treatment. There are a number of health concerns women … Read more

Advice for Parenting During Cancer Treatment

From telling children about a diagnosis to juggling school and sports schedules with treatment, parents face many unique emotional and logistical challenges when diagnosed with cancer. Sarah Silvia, a single mom treated at Dana-Farber for lymphoma, recently shared her experience during a live Dana-Farber webchat with Dana-Farber social workers Allison Dibiaso, LICSW, and Kelly Drummond, … Read more

Five Things You Need to Know About Colorectal Cancer Prevention [Infographic]

Updated April 13, 2015 While one of the most common cancers in both men and women, colorectal cancer remains a very preventable disease, says Jeffrey Meyerhardt, MD, MPH, clinical director of Dana-Farber’s Center for Gastrointestinal Oncology. “Most of these cancers develop over a period of years,” he says. “While not preventable in everyone, the earlier … Read more

You Are Not Alone: Supporting Siblings of Childhood Cancer Patients

When Phoebe Clark was 14-months old, she had little knowledge of what was happening to her brother, Harry. The 5-year-old had been diagnosed with a brain tumor and was undergoing multiple surgeries and radiation therapy at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. But a few years later, when Phoebe was 5-years old, her brother … Read more

Non-Hodgkin Lymphoma and Hodgkin Lymphoma: What’s the Difference?

Hodgkin and non-Hodgkin lymphoma are the two main types of lymphoma, a cancer that affects the lymphatic system. The lymphatic system produces and transports white blood cells to fight infection. While they have many characteristics in common, there are some significant differences between Hodgkin and non-Hodgkin lymphoma, including the age groups they affect, how they … Read more

What Is Cancer Immunotherapy?

Any treatment that uses elements of the body’s immune system to fight cancer is considered cancer immunotherapy. In recent years, as research has revealed many of the basic workings of the immune system and how the immune system interacts with tumor cells, scientists have developed, tested, and demonstrated the effectiveness of an array of immunotherapy … Read more

Immunotherapy, Targeted Drugs, Brain Cancer Research Among Highlights at Cancer Meeting

Eagerly awaited new data from trials of immunotherapy drugs, vaccines to treat brain tumors, and improved treatments for blood cancers sparked waves of optimism at the year’s biggest cancer meeting. The 2015 annual meeting of the American Society of Clinical Oncology (ASCO) drew about 30,000 cancer specialists to Chicago May 29 – June 2. Immunotherapy, … Read more

How a Cure for Hodgkin Lymphoma Changed the Course of Cancer Treatment

To mark its 50th anniversary, the American Society of Clinical Oncology (ASCO) invited physicians, patients, and the public to name the most important advances in clinical cancer research in the past half century. From more than 2,000 responses, the top choice was a cure for advanced Hodgkin lymphoma developed by scientists at the National Cancer … Read more